Design Therapeutics, Inc.
NASDAQ:DSGN
6.49 (USD) • At close December 26, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities: | |||||
| Net Income
| -66.862 | -63.308 | -35.533 | -8.28 | -2.047 |
| Depreciation & Amortization
| 0.537 | 0.406 | 0.129 | 0.005 | 0 |
| Deferred Income Tax
| 0 | 0 | -0.077 | -0.071 | 0 |
| Stock Based Compensation
| 13.088 | 10.925 | 4.689 | 0.45 | 0 |
| Change In Working Capital
| 0.728 | 1.992 | 1.396 | -0.811 | 1.813 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -1.246 | 5.385 | 2.413 | -0.413 | 0 |
| Other Working Capital
| 1.974 | -3.393 | -1.017 | -0.398 | 1.813 |
| Other Non Cash Items
| -6.051 | -1.332 | 0.019 | 0.038 | 0.095 |
| Operating Cash Flow
| -58.56 | -51.317 | -29.377 | -8.669 | -0.139 |
| Investing Activities: | |||||
| Investments In Property Plant And Equipment
| -0.256 | -0.918 | -1.538 | -0.076 | 0 |
| Acquisitions Net
| 0 | 0.039 | 0.052 | 0.033 | 0 |
| Purchases Of Investments
| -224.703 | -312.998 | -86.261 | -55.589 | 0 |
| Sales Maturities Of Investments
| 277.495 | 92.89 | 34.155 | 22.104 | 0 |
| Other Investing Activites
| 0 | 0.039 | -0.052 | -0.033 | 0 |
| Investing Cash Flow
| 52.536 | -220.987 | -53.644 | -33.561 | 0 |
| Financing Activities: | |||||
| Debt Repayment
| 0 | 0 | 0 | 44.531 | 0.196 |
| Common Stock Issued
| 0.724 | 0.662 | 254.271 | 0.001 | 0 |
| Common Stock Repurchased
| 0.305 | 0.339 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.724 | 0.235 | 124.94 | 0.001 | 0 |
| Financing Cash Flow
| 0.724 | 0 | 0.379 | 44.532 | 0.196 |
| Other Information: | |||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| -5.3 | -272.069 | 296.19 | 2.302 | 0.057 |
| Cash At End Of Period
| 21.2 | 26.5 | 298.569 | 2.379 | 0.077 |